Reproduction and Perinatal Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia.
Department of Diabetes and Endocrinology, Westmead Hospital, Sydney, NSW, 2145, Australia.
BMC Pregnancy Childbirth. 2023 May 12;23(1):341. doi: 10.1186/s12884-023-05659-6.
The COVID-19 pandemic has had indirect effects on pregnancy outcomes. There is limited data on the impact on gestational diabetes (GDM) in diverse populations and the possible underlying mediators. This study aimed to assess the risk of GDM pre-COVID-19 and in two distinct pandemic exposure periods, and to determine the potential factors contributing to increased risk in a multiethnic population.
A multicentre, retrospective cohort study was performed of women with singleton pregnancy receiving antenatal care at three hospitals two years pre-COVID-19 (January 2018 - January 2020), first year of COVID-19 with limited pandemic-mitigating restrictions (February 2020 - January 2021) and second year of COVID-19 with stringent restrictions (February 2021 - January 2022). Baseline maternal characteristics and gestational weight gain (GWG) were compared between cohorts. The primary outcome was GDM, assessed using univariate and multivariate generalised estimating equations models.
28,207 pregnancies met the inclusion criteria, 14,663 pregnancies two years pre-COVID-19, 6,890 in COVID-19 Year 1 and 6,654 in COVID-19 Year 2. Maternal age increased across exposure periods (30.7 ± 5.0 years pre-COVID-19 vs 31.0 ± 5.0 years COVID-19 Year 1 vs 31.3 ± 5 years COVID-19 Year 2; p < 0.001). There were increases in pre-pregnancy body mass index (BMI) (25.5 ± 5.7 kg/m vs 25.7 ± 5.6 kg/m vs 26.1 ± 5.7 kg/m; p < 0.001), proportion who were obese (17.5% vs 18.1% vs 20.7%; p < 0.001) and proportion with other traditional risk factors for GDM including South Asian ethnicity and prior history of GDM. Rate of GWG and proportion exceeding recommended GWG increased with pandemic exposure (64.3% vs 66.0% vs 66.6%; p = 0.009). GDM diagnosis increased across exposure periods (21.2% vs 22.9% vs 24.8%; p < 0.001). Both pandemic exposure periods were associated with increased risk of GDM on univariate analysis, only COVID-19 Year 2 remaining significantly associated after adjusting for maternal baseline characteristics and GWG (OR 1.17 [1.06, 1.28], p = 0.01).
Diagnosis of GDM increased with pandemic exposure. Progressive sociodemographic changes and greater GWG may have contributed to increased risk. However, exposure to the second year of COVID-19 remained independently associated with GDM after adjusting for shifts in maternal characteristics and GWG.
COVID-19 大流行对妊娠结局产生了间接影响。关于不同人群中妊娠期糖尿病(GDM)的影响以及潜在的潜在介导因素,数据有限。本研究旨在评估 COVID-19 前和两个不同大流行暴露期间 GDM 的风险,并确定在多民族人群中导致风险增加的潜在因素。
对在三家医院接受产前护理的单胎妊娠妇女进行了一项多中心、回顾性队列研究,时间为 COVID-19 前两年(2018 年 1 月至 2020 年 1 月)、COVID-19 大流行第一年(2020 年 2 月至 2021 年 1 月)有限大流行缓解限制期间和 COVID-19 第二年(2021 年 2 月至 2022 年 1 月)严格限制期间。比较了队列之间的基线产妇特征和妊娠体重增加(GWG)。主要结局是使用单变量和多变量广义估计方程模型评估的 GDM。
28207 例妊娠符合纳入标准,COVID-19 前两年 14663 例,COVID-19 年 1 年 6890 例,COVID-19 年 2 年 6654 例。暴露期间,产妇年龄增加(COVID-19 前 30.7±5.0 岁 vs. COVID-19 年 1 岁 31.0±5.0 岁 vs. COVID-19 年 2 岁 31.3±5.0 岁;p<0.001)。孕前体重指数(BMI)(25.5±5.7kg/m 与 25.7±5.6kg/m 与 26.1±5.7kg/m;p<0.001)、肥胖比例(17.5%与 18.1%与 20.7%;p<0.001)和包括南亚种族和既往 GDM 史在内的其他传统 GDM 危险因素的比例均有所增加。GWG 率和超过推荐 GWG 的比例随着大流行的暴露而增加(64.3%与 66.0%与 66.6%;p=0.009)。GDM 诊断在暴露期间增加(21.2%与 22.9%与 24.8%;p<0.001)。单变量分析显示,两个大流行暴露期间 GDM 的风险均增加,调整产妇基线特征和 GWG 后,仅 COVID-19 年 2 期仍与 GDM 显著相关(OR 1.17[1.06, 1.28],p=0.01)。
随着大流行的暴露,GDM 的诊断增加。社会人口统计学的渐进变化和更大的 GWG 可能导致风险增加。然而,在调整产妇特征和 GWG 变化后,暴露于 COVID-19 第二年与 GDM 仍独立相关。